Home › Funds › Sofinnova Investments, Inc. › AXSM
Sofinnova Investments, Inc. position in AXSM
AXSOME THERAPEUTICS INC. · Health Care
Sofinnova Investments, Inc. reported holding 445,906 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$82.2M, representing 3.71% of its reported portfolio and ranking #6 among its reported holdings. Sofinnova Investments, Inc. has disclosed AXSM holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Sofinnova Investments, Inc.'s AXSM position evolved
Sofinnova Investments, Inc. first disclosed a stake in AXSM in Q3 2023 at 80,368 shares (US$5.6M). The position peaked in Q3 2026 at 445,906 shares, worth US$82.2M. Across 11 filings, Sofinnova Investments, Inc. increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 445,906 shares valued at US$82.2M — an increase of 285,477 shares quarter over quarter.. Notable position changes include a 320% increase in Q3 2025 (shares rose 50% over the following quarter), a 1531% increase in Q1 2026 (shares rose 45% over the following quarter), a 178% increase in Q3 2026 (shares fell 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 80.37K | $5.62M | New |
| Q2 2024 | 310.20K | $24.97M | New |
| Q3 2024 | 150.00K | $13.48M | Reduce |
| Q4 2024 | 100.00K | $8.46M | Reduce |
| Q1 2025 | 175.32K | $20.45M | Add |
| Q2 2025 | 93.61K | $9.77M | Reduce |
| Q3 2025 | 393.50K | $47.79M | Add |
| Q4 2025 | 12.27K | $2.24M | Reduce |
| Q1 2026 | 200.00K | $33.80M | Add |
| Q2 2026 | 160.43K | $39.27M | Reduce |
| Q3 2026 | 445.91K | $82.22M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AXSM and 13F data
AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 42 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$147.5M), ALETHEA CAPITAL MANAGEMENT, LLC (US$119.7M), FRONTIER CAPITAL MANAGEMENT CO LLC (US$62.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AXSM
- Deep Track Capital, LP 800.00K sh · $147.51M · Q3 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 649.12K sh · $119.69M · Q3 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 254.28K sh · $62.24M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 300.10K sh · $55.34M · Q3 2026
- SAMLYN CAPITAL, LLC 289.25K sh · $53.33M · Q3 2026
More on Sofinnova Investments, Inc.
FAQ
How long has Sofinnova Investments, Inc. held AXSM?
Sofinnova Investments, Inc. has disclosed AXSM holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
What is Sofinnova Investments, Inc.'s current position in AXSM?
As of Q3 2026, Sofinnova Investments, Inc. holds 445.91K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $82.22M, representing 3.71% of its reported portfolio and ranking #6.
Has Sofinnova Investments, Inc. been buying or selling AXSM?
In the latest 13F filing (Q3 2026), Sofinnova Investments, Inc. increased its position in AXSM. The position peaked in Q3 2026 at 445.91K shares.
Which other funds hold AXSM?
Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.